Medical/Pharmaceuticals
Travecta Therapeutics Appoints Charles S. Ryan as President and Chief Executive Officer
SINGAPORE, June 9, 2021 /PRNewswire/ -- Travecta Therapeutics, Pte Ltd., a preclinical stage biopharmaceutical company pioneering a portfolio of product candidates engineered to cross the blood-brain-barrier, today announced the appointment ofCharles S. Ryan, JD, PhD as President and Chief Execut...
2021-06-09 21:00
1869
/C O R R E C T I O N -- Amorepacific/
In the news release, A green tea probiotic strain found by Amorepacific is added to the U.S. FDA's NDI list, issued08-Jun-2021 by Amorepacific over PR Newswire, we are advised by the company that the [in the second, third, fourth and fifth] paragraphs, there are few changes]" as originally issued...
2021-06-09 20:12
2661
China Pharma to Launch Highly Purified NMN+PQQ Product
HAIKOU, China, June 9, 2021 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced plans to launch a highly purified NMN+PQQ product following the recent successful completion of a pilot scale ...
2021-06-09 20:00
10131
European Patent Office upholds Curadev's cyclodextrin patent for new composition of matter
SANDWICH, England, June 9, 2021 /PRNewswire/ -- Sulphobutyl ether β-cyclodextrin (SBE-β-CD) is used as an excipient to improve the solubility and stability of a range of active pharmaceutical ingredients, prominent among which is the antifungal drug, voriconazole. Working with ProfessorSteve Wick...
2021-06-09 19:50
2155
Travecta Therapeutics Appoints Charles S. Ryan as President and Chief Executive Officer
SINGAPORE, June 9, 2021 /PRNewswire/ -- Travecta Therapeutics, Pte Ltd. incorporated inSingapore on 7th April 2017, a preclinical stage biopharmaceutical company pioneering a portfolio of product candidates engineered to cross the blood-brain-barrier, today announced the appointment of Charles S....
2021-06-09 13:38
2142
Product Quality is of the Utmost Importance, Visitors to the ICMD Impressed by ICP DAS-BMP Medical Grade TPU
HSINCHU, June 9, 2021 /PRNewswire/ -- The 31st International Component
Manufacturing & Design Show (ICMD) took place fromMay 13 to 16, 2021 at the
Shanghai National Convention and Exhibition Center. The event was a big
success, with industry heavyweights in attendance.
2021-06-09 11:11
3872
LivFul and Global Access Diagnostics announce partnership for COVID-19 test kit distribution
LIVERPOOL, England, June 9, 2021 /PRNewswire/ -- LivFul and Global Access Diagnostics (GAD) today announced a new partnership to make a variety of diagnostic kits, starting with COVID-19 rapid antigen tests, available in Low to Middle Income Countries. While new innovations are being developed, ...
2021-06-09 10:00
1877
Antengene's Partner Karyopharm Therapeutics Announces Updated Data of Eltanexor in Patients with Hypomethylating Agent Refractory MDS
--Of the 15 patients evaluable for efficacy, 7 (47%) had mCR and 5 (33%) had SD for a total disease control rate of 80%-- --Patients with mCR had longer mOS than patients without mCR or with PD-- SHANGHAI and HONG KONG, June 9, 2021 /PRNewswire/ -- Antengene's Partner, Karyopharm Therapeutics In...
2021-06-09 08:00
3628
Sirtex Medical provides donations to Massachusetts Institute of Technology (MIT) and Brigham and Women's Hospital in support of the Artzi Lab, as part of Sirtex's corporate citizenship strategy to support research and innovation
WOBURN, Mass., June 8, 2021 /PRNewswire/ -- Sirtex Medical (Sirtex), a leading manufacturer of targeted liver cancer therapies, has provided grants to Massachusetts Institute of Technology (MIT) and Brigham and Women's Hospital for the advancement of cancer treatment, to be shared with the indepen...
2021-06-08 20:30
1720
Innoforce Pharmaceuticals to Participate in BIO International Digital Convention
HANGZHOU, China and ROCKVILLE, Md., June 8, 2021 /PRNewswire/ -- Innoforce Pharmaceuticals ("Innoforce"), an innovation and partnership-focused biopharmaceutical company, today announces that the company is participating in the BIO International Digital Convention (BIO Digital) being held fromJun...
2021-06-08 19:00
2540
Neoss Announces NeossONE™ - One Platform, Smart Prosthetics
NeossONE™ is a solution unique to the Neoss® Implant System - one prosthetic platform, across three implant ranges, including ALL implant diameters and abutments. Simply put, the same prosthetic components fit every implant.¹ HARROGATE, England, June 8, 2021 /PRNewswire/ -- ONE Prosthetic Platfo...
2021-06-08 18:15
4070
TargEDys announces the publication of the first double-blind, randomized, placebo-controlled clinical trial showing Hafnia alvei's efficacy at an unprecedented level in weight loss and satiety
LONGJUMEAU, France, June 8, 2021 /PRNewswire/ -- The French biotech TargEDys specialized in breakthrough microbiome-based solutions announces the publication of its study conducted in 230 overweight adults supplemented for 12 weeks, confirming the efficacy of the precision probioticHafnia alvei H...
2021-06-08 16:53
4237
Inspiring Women's Healthcare: Mindray Unveils Nuewa I9, a New OB/GYN Diagnostic Ultrasound System
SHENZHEN, China, June 8, 2021 /PRNewswire/ -- Mindray (SZSE: 300760), a global
leading developer and provider of medical devices and solutions, has introduced
theNuewa I9
2021-06-08 15:37
9859
Copan strengthens its operations in the Americas with a millionaire investment
Copan announces a $78 million investment to expand its Puerto Rican production site. The project – partially financed byPuerto Rico's Government – will bring Copan production and distribution capacity closer to the American market, strengthening the company's presence in the US and the rest of th...
2021-06-08 14:00
3104
Onward Therapeutics Signs an Exclusive Collaboration and Worldwide Option and License Agreement with Institut du Cancer de Montpellier
EPALINGES, Switzerland, June 8, 2021 /PRNewswire/ -- Onward Therapeutics (Onward) and Institut du Cancer de Montpellier (ICM) announced today the execution of an exclusive collaboration and worldwide option and license agreement based on a research program in onco-metabolism being conducted by I...
2021-06-08 12:00
1741
Cytiva opens experience and learning lab in Singapore
* New lab will support Singapore government's Industry 4.0 agenda to build research, digital, innovation capability and talent development * Part of Cytiva's capacity expansion plan to meet the increasing demands for the biopharmaceuticals industry * Through this lab, Cytiva intends to run 7...
2021-06-08 10:00
2168
Innovent Biologics and IASO Biotherapeutics to Present Updated Data from its Anti-BCMA CAR-T Therapy in Relapsed/Refractory Multiple Myeloma at European Hematology Association (EHA) Congress
SAN FRANCISCO and SUZHOU, China, June 8, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...
2021-06-08 08:00
5355
Live from ASCO 2021 | Ascentage Pharma Delivers Oral Presentation Featuring Updated Data Demonstrating Promising Efficacy and Safety of Bcl-2 Inhibitor Lisaftoclax (APG-2575) in Patients with Relapsed or Refractory CLL/SLL
SUZHOU, China, and ROCKVILLE, MD, June 8, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today released updated results from the first...
2021-06-08 07:30
5384
Live from ASCO 2021 | Ascentage Pharma Presents Updated Results of MDM2-p53 Inhibitor Alrizomadlin (APG-115) Demonstrating an ORR of 24.1% Including Complete Response in Combination with Pembrolizumab in Patients with Advanced Melanoma Resistant or Refractory to Prior Immuno-Oncologic Drugs
SUZHOU, China, and ROCKVILLE, Md., June 8, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today presented in an oral presentation at t...
2021-06-08 07:21
12676
ORTHO OPTIX™ Reader Completes Transfusion Medicine Portfolio, Now Available in the United States and Puerto Rico
RARITAN, N.J., June 7, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced its semi-automated ORTHO OPTIX™ Reader, which allows lower-volume transfusion labs to elevate their standard of patient care ...
2021-06-07 21:00
6453
Week's Top Stories
Most Reposted
Edufrienz 99: One of Asia's First Digital Platform Advancing Character Education for Future-Ready, Compassionate Children
[Picked up by 319 media titles]
2026-01-23 11:03
Agoda Launches Agoda Impact Lab at ASEAN Tourism Forum
[Picked up by 317 media titles]
2026-01-29 15:06
Agoda Launches Open-Source API Agent to Simplify MCP Server Integrations
[Picked up by 309 media titles]
2026-01-27 13:00
UOB prices AUD2 billion in five-year senior unsecured notes
[Picked up by 307 media titles]
2026-01-23 09:00Nokia Strengthens Edge AI Capabilities Through Strategic Collaboration with Blaize on Hybrid Inference Solutions Across Asia Pacific Regions
[Picked up by 294 media titles]
2026-01-27 18:00
Most Read
Robo.ai Partners with The Ghazi Group to Power AI Compute Infrastructure Growth in MENA and Southeast Asia
2026-01-23 19:02
8324
